Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
21 drugs in development
By Therapeutic Area
top 6
R&D Momentum
83/100
Pipeline Velocity
60/100
Trial Completion Rate
76/100
Pipeline Concentration
18/100
Pipeline Freshness
75/100
Strategic Signals
Activity
Last 14 days
Novel Inflammatory Biomarkers Complement 5A and Hepcidin in Patients With Gaucher Disease (GD)
Effect of a Dual Orexin Receptor Antagonist on CSF Alzheimer's Disease Biomarkers
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
Social Determinants of Sleep and Obesity: Culturally Informing a Sleep Extension Intervention for African American Adults
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
Fast-Her: Fasting Effects on Breast Cancer Treatment
Sleep Trial to Prevent Alzheimer's Disease
The Impact of Injustice Appraisals on Psychosocial Outcomes Following Spinal Cord Injury: A Longitudinal Study
Brain Connectivity Patterns in Chronic Temporomandibular Joint Disorders
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)